Iguana Healthcare Management’s Immunomedics Inc IMMU Stock Holding History

Iguana Healthcare Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$5.84M	Sell	400,000 -50,000	-11%	-$817K	3.84%	3
2017 Q4	$7.27M	Sell	450,000 -50,000	-10%	-$590K	4.74%	3
2017 Q3	$6.99M	Buy	500,000 +175,000	+54%	+$1.74M	3.81%	3
2017 Q2	$2.87M	Sell	325,000 -25,000	-7%	-$176K	1.62%	26
2017 Q1	$2.27M	Buy	350,000 +50,000	+17%	+$253K	1.12%	28
2016 Q4	$1.1M	Sell	300,000 -300,000	-50%	-$888K	0.66%	43
2016 Q3	$1.95M	Buy	600,000 +375,000	+167%	+$1.05M	0.35%	68
2016 Q2	$522K	Buy	+225,000	New	+$752K	0.21%	76
2016 Q1	–	Sell	-400,000	Closed	-$1.23M	–	94
2015 Q4	$1.23M	Buy	+400,000	New	+$1.12M	0.4%	55
2015 Q2	–	Sell	-50,000	Closed	-$204K	–	90
2015 Q1	$192K	Buy	+50,000	New	+$217K	0.08%	62

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Iguana Healthcare Management's IMMU Position: Q1 2018 in Review

Iguana Healthcare Management reduced its Immunomedics Inc (IMMU) stake by 11% in Q1 2018, selling an estimated $817K and leaving 400,000 shares worth $5.84M. The position accounts for 3.84% of the portfolio, ranked #3.

Iguana Healthcare Management first reported a position in IMMU in Q1 2015 and has held it in 10 quarters since. The position peaked at $7.27M in Q4 2017. 168 funds tracked by Wall St. Rank hold IMMU as of Q1 2018.

Iguana Healthcare Management held 400,000 shares of Immunomedics Inc worth $5.84M as of Q1 2018.
Iguana Healthcare Management sold 50,000 Immunomedics Inc shares in Q1 2018, an estimated $817K.
Immunomedics Inc made up 3.84% of Iguana Healthcare Management's portfolio in Q1 2018, its #3 holding.
Iguana Healthcare Management first reported a position in Immunomedics Inc in Q1 2015 and has held it in 10 quarters since.
Iguana Healthcare Management's Immunomedics Inc position peaked at $7.27M in Q4 2017.
168 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.